Informazioni su DNIB Unwind Inc
Sito web | bindtherapeutics.com |
Fondato | 2006 |
Numero di dipendenti | 1-10 |
Industria | biotechnology |
Paese | US |
Stato | Massachusetts |
Città | Cambridge |
Indirizzo | -71.10 |
Numero di telefono | (617) 491-3400 |
Email pattern | {f}{last} |
Email Accept all Stato | False |
Email Blocked Stato | False |
Whois Data di creazione | February 27th 2013, 05:54:42 pm |
RWhois | www.markmonitor.co... |
Whois Name | MarkMonitor Inc. |
Total Emails | 36 |
Total Personal Emails | 32 |
Total Generic Emails | 4 |
Last updated | April 4th 2023, 09:05:41 pm |
Tutti gli indirizzi email per bindtherapeutics.com
nicholas boylann***@bindtherapeutics.com | scientist | 0 Sources |
tatiana sitnovat***@bindtherapeutics.com | Legal Director | 0 Sources |
dan koerwerd***@bindtherapeutics.com | chief business officer | 0 Sources |
scott minicks***@bindtherapeutics.com | ceo | 0 Sources |
christina serettac***@bindtherapeutics.com | hr associate | 0 Sources |
brenda duaneb***@bindtherapeutics.com | director hr | 0 Sources |
laurie traversl***@bindtherapeutics.com | staffing consultant | 0 Sources |
scott minicks***@bindtherapeutics.com | 0 Sources | |
jean kungj***@bindtherapeutics.com | clinical project manager data manager | 0 Sources |
peter endicottp***@bindtherapeutics.com | head facilities | 0 Sources |
26 altro per la tua ricerca bindtherapeutics.com
Crea un account per scoprire gli indirizzi e-mail, ottenere risultati completi, filtri di ricerca, download CSV e altro ancora.
Formato e-mail
Pattern | # | |
---|---|---|
johndoe@bindtherapeutics.com | {first}{last} | No |
john.doe@bindtherapeutics.com | {first}.{last} | No |
john-doe@bindtherapeutics.com | {first}-{last} | No |
doejohn@bindtherapeutics.com | {last}{first} | No |
doe.john@bindtherapeutics.com | {last}.{first} | No |
doe-john@bindtherapeutics.com | {last}-{first} | No |
jdoe@bindtherapeutics.com | {f}{last} | Available |
j.doe@bindtherapeutics.com | {f}.{last} | No |
j-doe@bindtherapeutics.com | {f}-{last} | No |
johnd@bindtherapeutics.com | {first}{l} | No |
john.d@bindtherapeutics.com | {first}.{l} | No |
john-d@bindtherapeutics.com | {first}-{l} | No |
djohn@bindtherapeutics.com | {l}{first} | No |
d.john@bindtherapeutics.com | {l}.{first} | No |
d-john@bindtherapeutics.com | {l}-{first} | No |
doej@bindtherapeutics.com | {last}{f} | No |
doe.j@bindtherapeutics.com | {last}.{f} | No |
doe-j@bindtherapeutics.com | {last}-{f} | No |
john@bindtherapeutics.com | {first} | No |
doe@bindtherapeutics.com | {last} | No |
jd@bindtherapeutics.com | {f}{l} | No |
j.d@bindtherapeutics.com | {f}.{l} | No |
j-d@bindtherapeutics.com | {f}-{l} | No |
dj@bindtherapeutics.com | {l}{f} | No |
d.j@bindtherapeutics.com | {l}.{f} | No |
d-j@bindtherapeutics.com | {l}-{f} | No |